Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study

Marco Herling; Claire Dearden; Francesco Zaja; Dima El‐Sharkawi; Wei Ding; Mar Bellido; Amit Khot; Lidwine W. Tick; Eric D. Jacobsen; Toby A. Eyre; Damien Roos‐Weil; Tapan Kadia; Elisa Lucchini; Natali Pflug; Matthew S. Davids; Germán Peña; Nabanita Mukherjee; Mohamed Badawi; Tamas Vizkelety; Philipp B. Staber

doi:10.1182/bloodadvances.2023012248

Related publications

Article2019

Safety and Efficacy of Ibrutinib in Combination with Venetoclax in Patients with Marginal Zone Lymphoma: Preliminary Results from an Open Label, Phase II Study

Sasanka M. Handunnetti, Amit Khot, Mary Ann Anderson, Piers Blombery, Kate Burbury, David Ritchie, Rodney J. Hicks, Besiat Birbirsa, Mathias Bressel, Juliana Di Iulio, David Westerman, Stephen Lade, Andrew W. Roberts, John F. Seymour, Constantine S. Tam

Article2015

Ibrutinib Therapy in Rituximab-Refractory Patients with Waldenström's Macroglobulinemia: Initial Results from an International, Multicenter, Open-Label Phase 3 Substudy (iNNOVATETM)

Meletios A Dimopoulos, Judith Trotman, Alessandra Tedeschi, Jeffrey Matous, David MacDonald, Constantine S. Tam, O. Tournilhac, Shuo Ma, Albert Oriol, Leonard T. Heffner, Chaim Shustik, Ramón García‐Sánz, Robert F. Cornell, Carlos Fernández de Larrea, Jorge J. Castillo, Miquel Granell, Marie‐Christine Kyrtsonis, Véronique Leblond, Argiris Symeonidis, Priyanka Singh, Jianling Li, Thorsten Graef, Elizabeth Bilotti, Steven P. Treon, Christian Buske

Article2018

Ibrutinib Treatment in Waldenström's Macroglobulinemia: Follow-up Efficacy and Safety from the iNNOVATETM Study

Christian Buske, Alessandra Tedeschi, Judith Trotman, Ramón García‐Sánz, D. Blair Macdonald, Véronique Leblond, Beatrice Mahé, Charles Herbaux, Constantine S. Tam, M. Lia Palomba, Jeffrey Matous, Chaim Shustik, Eftathios Kastritis, Steven P. Treon, Chih‐Jian Lih, Jianling Li, Zeena Salman, Thorsten Graef, Meletios A Dimopoulos

Article2011

Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route

Claire Dearden, Amit Khot, Monica Else, Michael R. Hamblin, Effie Grand, Ashok Roy, Saman Hewamana, Estella Matutes, Daniel Catovsky

Article2023

CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study

Adrian Minson, Nada Hamad, Chan Y. Cheah, Constantine S. Tam, Piers Blombery, David Westerman, David Ritchie, Huw Morgan, Nicholas Holzwart, Stephen Lade, Mary Ann Anderson, Amit Khot, John F. Seymour, Molly Robertson, Imogen Caldwell, Georgina L. Ryland, Javad Saghebi, Zahra Sabahi, Jing Xie, Rachel Koldej, Michael Dickinson